Clinical Trial Update: Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating individualized induction therapy for non-elderly adults with adverse-risk acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Adult | Phase 2 | Status: UNKNOWN